J. Reiffers

发表

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

R. Larson, A. Saven, F. Mandelli, 2002, Blood.

Philadelphia chromosome-positive acute lymphoid leukemias A phase 2 study of imatinib in patients with relapsed or refractory

M. Baccarani, C. Sawyers, B. Druker, 2009 .

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.

C. Sawyers, H. Kantarjian, B. Druker, 2008, Blood.

Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase

E. Solary, C. Chastang, D. Coso, 2002, Leukemia.

Chromosome 8 tetrasomies and pentasomies--a clonal abnormality closely associated with acute monocytic leukaemia.

J. Abgrall, N. Dastugue, I. Luquet, 1997, Leukemia & lymphoma.

A Randomized Prospective Multicentre Trial of Cefpirome Versus Piperacillin-Tazobactam in Febrile Neutropenia

O. Boulat, F. Bauduer, J. Reiffers, 2001, Leukemia & lymphoma.

Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.

H. Tilly, P. Fenaux, X. Troussard, 1993, Leukemia.

Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the ebmt registry

G. Gahrton, A. Gratwohl, O. Ringdén, 1988, Hematological oncology.

[Sebaceous hyperplasias, kerato-acanthomas, epitheliomas of the face and cancer of the colon. A new entity?].

J. Reiffers, N. Hunziker, P. Laugier, 1976, Dermatologica.

Manifestations cutanes provoques par le lithium

P. Dick, J. Reiffers, 1977 .

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.

R. Bouabdallah, H. Dombret, F. Mandelli, 1995, The New England journal of medicine.

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Sante Tura, Thomas Fischer, Alois Gratwohl, 2002, Blood.

Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT.

G. Meloni, A. Gratwohl, J. Goldman, 1994, Bone marrow transplantation.

study : Presented in part at the 43rd Annual Meeting of The American chronic myelogenous leukemia in myeloid blast crisis: results of a phase II Imatinib induces hematologic and cytogenetic responses in patients with

R. Larson, F. Mandelli, N. Russell, 2013 .

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

M. Baccarani, C. Sawyers, B. Druker, 2002, Blood.

Clinical Observations, Interventions, and Therapeutic Trials

M. Baccarani, C. Sawyers, G. Juliusson, 2000 .

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.

J. Neglia, H. Sather, B. Druker, 2002, Blood.

Chronic granulocytic aplasia with partial blastic bone marrow involvement. Demonstration of myeloid origin of the blasts by ultrastructural detection of myeloperoxidase. A study of three cases.

F. Reyes, B. Dreyfus, J. Reiffers, 1980, Leukemia research.